A phase I/II clinical trial of cisplatin, and raltitrexed in patients with metastatic breast cancer refractory to anthracycline therapy.

被引：0
|
作者：
Rapoport, B
Mahomed, R
Uys, A
机构：
[1] Univ Pretoria, Dept Med Oncol, ZA-0001 Pretoria, South Africa
[2] Med Oncol Ctr Rosebank, Johannesburg, South Africa
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
140P
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [1] Phase II trial of paclitaxel (P) and cisplatin (CDDP) in patients with advanced breast cancer refractory to anthracycline (A) therapy
    Riccardi, F
    Rosati, G
    Biglietto, M
    Carteni, G
    DeRosa, P
    Tucci, A
    Pacilio, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 714 - 714
  • [2] Oral Gossypol in the Treatment of Patients with Refractory Metastatic Breast Cancer: A Phase I/II Clinical Trial
    Catherine Van Poznak
    Andrew D. Seidman
    Marcus M. Reidenberg
    Mark M. Moasser
    Nancy Sklarin
    Kimberly Van Zee
    Patrick Borgen
    Marc Gollub
    Doreen Bacotti
    T-J Yao
    Renny Bloch
    Monica Ligueros
    Martin Sonenberg
    Larry Norton
    Clifford Hudis
    [J]. Breast Cancer Research and Treatment, 2001, 66 : 239 - 248
  • [3] An phase II trial of docetaxel and cisplatin as first-line therapy for anthracycline-naive metastatic breast cancer patients
    Shen, Wen-Chi
    Chang, Hsien-Kun
    Chen, Jen-Shi
    Lin, Yung-Chang
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 86 - 86
  • [4] Oral gossypol in the treatment of patients with refractory metastatic breast cancer: A phase I/II clinical trial
    Van Poznak, C
    Seidman, AD
    Reidenberg, MM
    Moasser, MM
    Sklarin, N
    Van Zee, K
    Borgen, P
    Gollub, M
    Bacotti, D
    Yao, TJ
    Bloch, R
    Ligueros, M
    Sonenberg, M
    Norton, L
    Hudis, C
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2001, 66 (03) : 239 - 248
  • [5] Docetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthracycline treatment: a phase II clinical trial
    Park, SH
    Cho, EK
    Bang, SM
    Shin, DB
    Lee, JH
    Lee, YD
    [J]. BMC CANCER, 2005, 5 (1)
  • [6] Docetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthracycline treatment: a phase II clinical trial
    Se Hoon Park
    Eun Kyung Cho
    Soo-Mee Bang
    Dong Bok Shin
    Jae Hoon Lee
    Young Don Lee
    [J]. BMC Cancer, 5
  • [7] Phase II trial of paclitaxel and cisplatin in metastatic breast cancer refractory to anthracyclines
    Firvida-Perez, J
    Garcia-Mata, J
    Salgado, M
    Montanos, M
    Rodriguez, R
    [J]. 10TH INTERNATIONAL CONGRESS ON SENOLOGY - BREAST DISEASES OF THE SENOLOGIC INTERNATIONAL SOCIETY, 1998, : 759 - 763
  • [8] A phase II study of paclitaxel/cisplatin combination in patients with metastatic breast cancer refractory to anthracycline-based chemotherapy
    Rosati, G
    Riccardi, F
    Tucci, A
    De Rosa, P
    Pacilio, G
    [J]. TUMORI, 2000, 86 (03) : 207 - 210
  • [9] Phase I/II clinical trial of gene therapy for hormone refractory metastatic prostate cancer
    Gotoh, A
    Terao, S
    Shirakawa, T
    [J]. JOURNAL OF GENE MEDICINE, 2006, 8 (03): : 371 - 372
  • [10] A phase I clinical trial of cisplatin and raltitrexed in newly diagnosed patients with metastatic carcinoma of unknown primary (CUP).
    Raats, J
    Rapoport, B
    Mahomed, R
    Uys, A
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 137 - 137
12345